Zobrazeno 1 - 10
of 2 265
pro vyhledávání: '"mabs"'
Autor:
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, Lina M. Ismail, Adham Ezz El-Regal Mahmoud, Walid F. Elkhatib, Heba Aboul-Ella
Publikováno v:
Molecular Biomedicine, Vol 5, Iss 1, Pp 1-44 (2024)
Abstract Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound annual growth
Externí odkaz:
https://doaj.org/article/d8db5e7cec4d4870a337c03fbb191bb3
Autor:
Qi Pan, Xiaomin Xing, Jianhai Yu, Qiang Chen, Haizhan Jiao, Wanqin Zhang, Yingfen Wen, Ming Gao, Wei Zhao, Lei Yu, Hongli Hu
Publikováno v:
hLife, Vol 2, Iss 10, Pp 527-541 (2024)
Antibodies targeting non-structural protein 1 (NS1) confer protection against Zika virus (ZIKV). Although monoclonal antibodies (MAbs) 3G2 and 4B8 are more potent than MAb 4F10 in suppressing ZIKV infection in neonatal mice models, the epitopes are u
Externí odkaz:
https://doaj.org/article/61d25f68b43e4ecbb7e58764238adbda
Autor:
Hélène Banoun
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 9, Pp 10369-10395 (2024)
Respiratory infections with respiratory syncytial virus (RSV) account for an important part of hospital admissions for acute respiratory infections. Nirsevimab has been developed to reduce the hospital burden of RSV infections. Compared with the prod
Externí odkaz:
https://doaj.org/article/95e6886d4c7a4808b761a00eb9cf3ea5
Autor:
Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Sekh Thanprasertsuk, Wanakorn Rattanawong
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Most real-world data on CGRP mAbs have been published from high-income countries such as the USA, Western countries, Japan, Korea, and Singapore. However, data from low- and middle-income countries in Southeast Asia is lacking. Th
Externí odkaz:
https://doaj.org/article/8e64752ba0164aa29ab5d17aa93586a1
Autor:
Mario Rivera-Izquierdo, Arturo Morales-Portillo, Inmaculada Guerrero-Fernández de Alba, Nicolás Francisco Fernández-Martínez, Joan Antoni Schoenenberger-Arnaiz, José Luis Barranco-Quintana, Carmen Valero-Ubierna
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 887-910 (2024)
Introduction Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics r
Externí odkaz:
https://doaj.org/article/5cc042de4c474f45a384a3ba586260ed
Autor:
Hongyu Qiu, Xin-Yong Yuan, Kimberly Holloway, Heidi Wood, Teresa Cabral, Chris Grant, Peter McQueen, Garrett Westmacott, Daniel R. Beniac, Lisa Lin, Michael Carpenter, Darwyn Kobasa, Tom Gräfenhan, Ian Wayne Cheney
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35325- (2024)
Rapid antigen test (RAT) is widely used for SARS-CoV-2 infection diagnostics. However, test sensitivity has decreased recently due to the emergence of the Omicron variant and its sublineages. Here we developed a panel of SARS-CoV-2 nucleocapsid prote
Externí odkaz:
https://doaj.org/article/58d0d5e57f6643e6912fcacc854a3573
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Maedi-visna virus (MVV) and caprine arthritis encephalitis virus (CAEV) are members of a group of genetically highly homologous lentiviruses collectively referred to as small ruminant lentiviruses (SRLVs). SRLVs can infect sheep, goats and other smal
Externí odkaz:
https://doaj.org/article/e368d6aa603945a9a0c8ac1f68a1a0d0
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-16 (2024)
Abstract Background Migraine is a highly prevalent neurological disease with a substantial societal burden due to lost productivity. From a societal perspective, we assessed the cost-effectiveness of eptinezumab for the preventive treatment of migrai
Externí odkaz:
https://doaj.org/article/fca3cd0fb19d4594a041cd2b7b168b47
Publikováno v:
Hematology Reports, Vol 16, Iss 1, Pp 151-163 (2024)
Inhibitors of the factor FXI represent a new class of anticoagulant agents that are facing clinical approval for the treatment of acute coronary syndrome (ACS), venous thromboembolism (VTE), and stroke prevention of atrial fibrillation (AF). These ne
Externí odkaz:
https://doaj.org/article/83996f99dfda433892c5dd06ff869f49
Autor:
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 465-473 (2024)
Abstract Introduction The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In clinical practice gepants might be considered as a valid option to treat acute attacks in
Externí odkaz:
https://doaj.org/article/5a5d294c06a149ed8eaeedc5afe616a2